GlassScriptPhysician profile
Lissette Cortes-Meyer
NPI 1598035610
$4,825.13
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,134 · 2022: $936 · 2023: $1,071 · 2024: $1,685.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,803 · Travel and Lodging: $935 · Education: $17.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,802.59 |
| Travel and Lodging | $935.42 |
| Education | $17.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,792.41 | 2021-2024 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor, Mylux Patient Kit With Mobile Device |
| Merck Sharp & Dohme LLC | $586.16 | 2021-2023 | Verquvo, Belsomra |
| Astrazeneca Pharmaceuticals LP | $493.54 | 2021-2024 | Farxiga, Lokelma |
| Boehringer Ingelheim Pharmaceuticals, INC. | $365.68 | 2021-2024 | Jardiance |
| Amgen INC. | $347.65 | 2021-2024 | Repatha |
| Amarin Pharma, INC. | $267.96 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $239.28 | 2022-2024 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $230.04 | 2021-2024 | Lifevest |
| Gilead Sciences, INC. | $125.00 | 2024 | Livdelzi |
| Esperion Therapeutics, INC. | $93.06 | 2021-2023 | Nexletol |
| Janssen Pharmaceuticals, INC | $68.71 | 2021-2022 | |
| Pfizer INC. | $64.23 | 2023-2024 | |
| Alnylam Pharmaceuticals INC. | $41.83 | 2022 | |
| Novo Nordisk INC | $40.11 | 2023 | Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $37.81 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $19.76 | 2024 | |
| Abbott Laboratories | $11.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lissette Cortes-Meyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.